| Literature DB >> 26291128 |
Philippe Rousseau1, Chantal Autexier1,2.
Abstract
The key step of carcinogenesis is the malignant transformation which is fundamentally a telomere biology dysfunction permitting cells to bypass the Hayflick limit and to divide indefinitely and uncontrollably. Thus all partners and structures involved in normal and abnormal telomere maintenance, protection and lengthening can be considered as potential anti-cancer therapeutic targets. In this Point of View we discuss, highlight and provide new perspectives from the current knowledge and understanding to position the different aspects of telomere biology and dysfunction as diagnostic, preventive and curative tools in the field of cancer.Entities:
Keywords: alternative lengthening of telomere; cancer diagnostics; cancer therapeutics; shelterin; telomerase; telomere; telomere uncapping
Mesh:
Substances:
Year: 2015 PMID: 26291128 PMCID: PMC4829327 DOI: 10.1080/15476286.2015.1081329
Source DB: PubMed Journal: RNA Biol ISSN: 1547-6286 Impact factor: 4.652